高级检索
    刘思阳, 吴一龙. 中国PD-1/PD-L1抑制剂治疗肺癌临床试验概况[J]. 循证医学, 2017, 17(5): 259-259. DOI: 10.12019/j.issn.1671-5144.2017.05.002
    引用本文: 刘思阳, 吴一龙. 中国PD-1/PD-L1抑制剂治疗肺癌临床试验概况[J]. 循证医学, 2017, 17(5): 259-259. DOI: 10.12019/j.issn.1671-5144.2017.05.002
    shu
    LIU Si-yang, WU Yi-long. Ongoing Clinical Trials of PD-1 and PD-L1 Inhibitors for Lung Cancer in China[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 259-259. DOI: 10.12019/j.issn.1671-5144.2017.05.002
    Citation: LIU Si-yang, WU Yi-long. Ongoing Clinical Trials of PD-1 and PD-L1 Inhibitors for Lung Cancer in China[J]. Journal of Evidence-Based Medicine, 2017, 17(5): 259-259. DOI: 10.12019/j.issn.1671-5144.2017.05.002
    shu

    中国PD-1/PD-L1抑制剂治疗肺癌临床试验概况

    Ongoing Clinical Trials of PD-1 and PD-L1 Inhibitors for Lung Cancer in China

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回